BETH ISRAEL DEACONESS MEDICAL CENTER
Ad26 Based Therapeutic Vaccines for HIV
Ad26 Based Therapeutic Vaccines for HIV is a funding opportunity from BETH ISRAEL DEACONESS MEDICAL CENTER, up to 1503450, closing April 30, 2027.
Apr 30, 2027
(273d left)Overview
The goal of therapeutic vaccination is to increase host immune control of HIV-1 to achieve durable virologic control in the absence of ART, which is defined as a “functional cure”. However, therapeutic vaccine studies in humans have to date been largely unsuccessful. We speculate that this may reflect the fact…